Polysubstance use is common, particularly amongst some age groups and subcultures. It is also associated with elevated risk of psychiatric and physical health problems. We review the recent research findings, comment on changes to polysubstance diagnoses, report on contemporary clinical and epidemiological polysubstance trends, and examine the efficacy of preventive and treatment approaches.
INTRODUCTION
The term 'polysubstance use' broadly describes the consumption of more than one drug over a defined period, simultaneously or at different times for either therapeutic or recreational purposes. In substance use prevention and treatment, it usually refers to multiple illicit drug use, but it can also include licit and prescription medication used for nonmedical purposes.
Diagnostically, there have been some changes since the introduction of the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) [1 & ] that relate to the substance use disorder spectrum, and polysubstance dependence specifically. Polysubstance dependence has been removed from DSM-5. It was historically diagnosed by the use of three or more substances (excluding caffeine and nicotine) with no single substance dominating. Key to diagnosis was the lack of a specific drug preference, with the primary motivation for use being uninterrupted intoxication. Dependence criteria also needed to be met for substances as a group, but not for any individual substance. The diagnostic terms of 'Abuse' and 'Dependence' for all substances have also been removed from DSM-5 based on evidence for unidimensionality of diagnostic criteria [2 small but clinically unique group of patients who previously met DSM Polysubstance Dependence criteria will now be subsumed into a broader diagnostic umbrella. This may have implications from a comparative, epidemiological standpoint -although most population level research has not included diagnostic criteria or severity, only frequency of substance use. The prospective clinical implications are not yet known, nor is the reliability of clinical assessments of the DSM-5 severity index.
This review examines the key polysubstance use research published predominately over the last 18 months. Studies thematically cluster around using innovative statistical methods to describe polysubstance trends, recent evidence of psychiatric and physical health risks for multiple substance users, and advances in imaging and neuropsychological research on polysubstance users. We also review the evidence for prevention and treatment, and recommend how recent research could be integrated to maximize the efficacy of prevention and treatment approaches to polysubstance use.
REASONS FOR USE
There are many reasons why some people choose to use multiple rather than single substances. It can be to enhance effects, by combining drugs with similar central nervous system (CNS) mechanisms such as alcohol and benzodiazepines [3] or two or more anxiolytic-hypnotics [4] . Drugs with different CNS actions may also be combined to accentuate the perceived benefits of each substance, for example, opioids and benzodiazepines [5] [6] [7] , stimulants and opioids [8] , and stimulants and hallucinogens [9] .
Substances are used simultaneously or sequentially to ameliorate the adverse effects of drug craving or withdrawal. For example, stimulants are used to overcome dysphoria, and CNS depressants, such as benzodiazepines, to manage withdrawal symptoms of anxiety and agitation. Opportunistic access, experimentation, and conformity to subculture substance use norms are also motivators for multiple drug use. Substance users can be proficient at assessing the cost and benefit ratios of drug effects, and their use is frequently driven by market forces. The well documented reduction in the availability of heroin in Australia (c. 2000) saw heroin use increasingly supplemented with amphetamines [10] . As with other drug use, polysubstance use is more common amongst socioeconomic disadvantage [11] . It is especially common in some subcultures such as 'ravers' (dance club attendees), with recent reports of up to 75% using multiple substances, with on average five drugs used at the last rave attended [12] . Opportunistic and experimental drug use can establish powerful positive drug outcome expectancies that reinforce ongoing use and elevate risk of dependence [13] .
There has been increased media interest [14] in the combined use of caffeine (in the form of 'energy' drinks) and alcohol, reportedly to extend and enhance intoxication. Short-term behavioural effects and perceived levels of elevated synergistic intoxication have not been found in experimental studies using low doses of caffeine and alcohol [ ]. Latent class analysis (LCA) analyses of a comprehensive range of drugs reveal that drug use profiles fall into a small number of clusters of increasing drug involvement. These have included a limited-range cluster (who use alcohol, tobacco, and marijuana), a moderate-range cluster (in which amphetamine derivatives are added), and an extended-range cluster (in which there is nonmedical use of prescription drugs and other illicit drugs is added) [22 && -24 && , 31]. Figure 1 conceptually displays the three main clusters of drug use identified in LCAs for substance using respondents (cluster prevelance not to scale).
Since [32] . These overall findings suggest that use of certain drugs may occur in the context of other drug use (e.g., alcohol use increases the risk of experimentation with smoking [33] ). Research on simultaneous polysubstance use in this age group is needed to clarify the extent to which this occurs. In older groups, those who report polysubstance use in the last 12 months are also very likely to report simultaneous use [22 && ]. Non-medical prescription drug use (NMPDU) has gained recent attention. In the US National Survey on Drug Use and Health [34] , 6.3% (>12 years) reported NMPDU in the last year and 2.7% reported NMPDU use in the last month. Prevalence rates were 4.8% for pain relievers, 2.1% for tranquilizers, 1.2% for stimulants, and 0.3% for sedatives. Rates were higher in those aged 18-25 years (14.4-15.5% for last year) than in 12-17 year olds (7.8-8.7%) and those aged 26 years and older (3.8-4.8%). In a Nationally representative sample of US high school seniors (modal age 18 years), lifetime prevalence of nonmedical benzodiazepines use was 7.5% [35] . Nonmedical users of prescription opioids have higher rates of alcohol and illegal drug use than medical ].
Limited range polysubstance use in adolescence may increase the risk of expanded polysubstance use in young adulthood. Panel survey designs show that in the teen years (12-17 years), extended range polysubstance use is comparatively rare (2%), but is much higher (13 
COMORBID PSYCHOPATHOLOGY AND HEALTH
LCA show that those reporting the use of wideranging multiple substances have poorer mental health than those who use no or few substances. For example, they report higher levels of general psychological distress [22 && ,23 && ] and more symptoms of anxiety and depression [31] . Alcohol users who are classified by LCA as having concurrent illicit drug use are more likely to have generalized anxiety and major depressive disorders [40] . In a treatmentseeking, cannabis-using population, wide-ranging substance users identified by LCA had higher levels of depression, anxiety, manic excitement, and more positive psychotic symptoms than patients who used no other illicit substances [41 && ]. LCA studies have also identified elevated sexual risk behaviours and infectious disease prevalence amongst polysubstance users [42, 43] . Polysubstance use is especially prevalent in treatment-seeking substance abusers [44] , sexual health high-risk populations including men who have sex with men (MSM) [45] , HIVinfected MSM [46] , and transgender women [47] .
A number of recent studies and reviews have reminded the health community of the often underrecognized dangers of combining benzodiazepines and opiates for recreational use or to manage chronic pain [6,7,48 & ]. In a large national Danish sample [6] , long-term opiate users with chronic pain carried a 27 times higher odds ratio (95% confidence interval 14.85-49.15) of long-term use of benzodiazepines abuse than individuals without chronic pain. It is not entirely clear why patients with chronic pain are more likely to abuse opiates with benzodiazepines. A recent review [7] suggests that recreational consumption of benzodiazepines is the primary motivation, rather than previously documented self-medication hypotheses. Regardless of the motivations for use, patients who use both benzodiazepines and opioids are at higher risk of nonfatal and fatal overdoses [48 & ], comorbid mental and physical conditions, and forensic problems [7] .
IMAGING AND NEUROPSYCHOLOGY STUDIES
Imaging studies suggest that the abuse of multiple substances may have a cumulative or synergistic adverse effect on brain function and neurocognition [49] . Abstinent polysubstance abusers have reduced gray matter in the right temporal pole and medial frontal lobe, including the superior, cingulated, and paracingulate gyri [50 & ]. Abé et al. [51 && ] employed high-field brain magnetic resonance spectroscopy to study differences in brain metabolite concentrations in polysubstance abuse. Polysubstance abusers were defined as meeting DSM-IV criteria for dependence on alcohol in addition to one or more psychostimulants (mostly cocaine). At 1-month abstinence, polysubstance abusers had significantly lower concentrations of N-acetylaspartate, creatine, myoinositol, and choline-containing metabolites in the dorsolateral prefrontal cortex than alcohol-dependent individuals, who did not differ from healthy controls. This suggests cocaine may be more injurious than alcohol. Amongst polysubstance abusers, levels of N-acetylaspartate metabolites in this region were strongly correlated with deficits in visuospatial and working memory performance. This suggests that long-lasting memory deficits in polysubstance abusers may be the result of persistent abnormalities in neuronal integrity. Myoinositol abnormalities have been detected in the temporal cortex, cerebellar vermis, and lenticular nucleus, but these were not associated with cognitive performance [52] . In neither of the studies were these abnormalities related to the severity of consumption.
The relationships between brain function and drug doses may differ according to age, the substances abused, or how 'dose' is measured. Dose-related abnormalities in frontal N-acetylaspartate have been reported in adolescent polysubstance abusers compared to cannabis-dependent individuals and controls, suggesting a greater vulnerability to neurotoxicity in younger polysubstance users [53] . Dose-response relationships were observed for methamphetamine and cannabis, but only in polysubstance users, suggesting a synergistic effect of combined use. Dose-related alterations in cortical serotonin signalling have also been observed in long-term abstinent polysubstance users, but these were specific to 3,4-methylenedioxymethamphetamine (MDMA), suggesting a unique role in serotonin neurotoxicity [54] . Other studies have shown dose-dependent associations between MDMA and brain activity in the parahippocampal gyrus and superior parietal lobule during memory encoding but not retrieval [55, 56] . Taken together, recent findings suggest psychostimulant abuse in polysubstance users is particularly injurious. However, these studies, and other recent investigations of inhibitory control [57] and decision-making [58] , find no difference in the behavioural performance between polysubstance abusers and controls. This contrasts with the body of neuropsychological evidence of impairments resulting from substance abuse [59, 60] .
Some have interpreted the discrepancy between neural and behavioural outcomes as reflecting the engagement of compensatory processes to achieve equivalent performance [56, 57] . It is also possible that neuropsychological tasks adapted and simplified for the scanner lack sensitivity or that neuroimaging studies lack sufficient sample sizes for adequate statistical power [61] . Large differences have been reported in behavioural performance between polysubstance abusers and controls on standardized neuropsychological tests of working memory, inhibition, cognitive flexibility, self-regulation, and decision-making (administered outside the scanner [62] ). Test performance correlated with resting brain metabolism in the right middle temporal pole (working memory), right calcarine and bilateral posterior cingulate (self-regulation), and right middle and superior frontal cortices (decision-making). However, only severity of cocaine use was related to brain metabolism (right middle temporal pole). Therefore, although polysubstance abuse is clearly associated with deficits in brain function and cognition, elucidating more specific relationships is made difficult by the methodological differences between studies, differences in the wide range of substances abused, and possibly reduced statistical power in neuroimaging studies [61,63 & ].
PREVENTION, TREATMENT, AND FURTHER RESEARCH
Prevention programs delivered in schools and community to reduce youth substance use generally demonstrate modest efficacy, with some studies showing small short-term effects, but poor longer term outcomes [64] [65] [66] . When prevention programs that specifically target adult polysubstance users are reviewed, pervasive methodological weaknesses prevent strong conclusions being drawn about efficacy [67] . Psychological treatments for alcohol, cannabis, tobacco, and amphetamine are effective in reducing the severity of disorders, as are pharmacological approaches to opiate, nicotine, and alcohol dependence [68] . There is currently limited evidence to assess whether treating multiple substance problems concurrently is more effective than treating them individually and sequentially.
There is an intuitive appeal for targeting prevention and treatment approaches based on the individual risk profiles (T. Dietrich, S.R. Rundle-Thiele, C. Leo, J.P. Connor, in preparation) [69, 70] . Some promising prevention results targeting personality risk have recently been reported at 24 months' followup [71 & ]. Future research may consider whether specific types of polysubstance clusters, as identified in the current review, respond better to targeted prevention and treatment approaches.
Future ] will help identify patterns of both 'forward' and 'backward' transitioning (widening or narrowing of drug types). These statistical technologies may be helpful in determining the timings for prevention targets for specific drug types and combinations of drugs. Future research would also benefit from more precisely identifying the source of prescription medication used for non-medical purposes. It is possible individuals that source non-prescription medicine from registered heath prescribers may represent a fundamentally different type of substance users to those who access street markets for both diverted prescription (and overthe-counter drugs) drugs and illicit drugs.
CONCLUSION
It is clear that individuals who use multiple substances are at elevated risk of developing comorbid psychiatric and other health conditions. They also have more pervasive deficits in cognitive functioning that place them at elevated risk of poorer treatment outcomes. Prevention and treatment approaches for polysubstance use are underdeveloped by comparison with treatments for abuse of single substances. Future research will tell what effects removing polysubstance dependence from DSM-5 will have on the identification and treatment of this group of substance users.
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